DOC1021 Dendritic Cell Immunotherapy for Refractory Melanoma

Clinical trial NCT07288112 · RECRUITING

Trial details

NCT number: NCT07288112
Sponsor: Diakonos Oncology Corporation
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Refractory Melanoma

Start date: 2026-04-06
Primary completion: 2031-01-01
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.